OCULAR THERAPEUTIX, INC financial data

Symbol
OCUL on Nasdaq
Location
Bedford, MA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 04 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 962% % -30%
Quick Ratio 7.5% % -4.5%
Debt-to-equity 51% % 9.4%
Return On Equity -87% % -54%
Return On Assets -58% % -49%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 213,047,472 shares 36%
Common Stock, Shares, Outstanding 174,949,558 shares 12%
Entity Public Float $1,063,600,000 USD 162%
Common Stock, Value, Issued $18,000 USD 12%
Weighted Average Number of Shares Outstanding, Basic 183,919,808 shares 10%
Weighted Average Number of Shares Outstanding, Diluted 183,919,808 shares 10%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $55,784,000 USD -9.2%
Research and Development Expense $187,285,000 USD 82%
Selling and Marketing Expense $51,805,000 USD 30%
General and Administrative Expense $61,316,000 USD 13%
Costs and Expenses $306,616,000 USD 51%
Operating Income (Loss) $250,832,000 USD -78%
Nonoperating Income (Expense) $1,159,000 USD -108%
Net Income (Loss) Attributable to Parent $249,673,000 USD -43%
Earnings Per Share, Basic -1 USD/shares -6.1%
Earnings Per Share, Diluted -1 USD/shares -28%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $344,772,000 USD -19%
Accounts Receivable, after Allowance for Credit Loss, Current $30,768,000 USD 1.8%
Inventory, Net $3,488,000 USD 45%
Assets, Current $386,980,000 USD -18%
Property, Plant and Equipment, Net $16,954,000 USD 69%
Operating Lease, Right-of-Use Asset $5,334,000 USD -6.3%
Assets $410,882,000 USD -16%
Accounts Payable, Current $6,260,000 USD 56%
Employee-related Liabilities, Current $13,052,000 USD 18%
Accrued Liabilities, Current $40,272,000 USD 32%
Contract with Customer, Liability, Current $64,000 USD -76%
Liabilities, Current $49,294,000 USD 36%
Contract with Customer, Liability, Noncurrent $14,000,000 USD 0%
Operating Lease, Liability, Noncurrent $3,629,000 USD -35%
Other Liabilities, Noncurrent $151,000 USD 29%
Liabilities $152,653,000 USD 10%
Retained Earnings (Accumulated Deficit) $1,092,369,000 USD -30%
Stockholders' Equity Attributable to Parent $258,229,000 USD -27%
Liabilities and Equity $410,882,000 USD -16%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $44,671,000 USD -32%
Net Cash Provided by (Used in) Financing Activities $4,183,000 USD -99%
Net Cash Provided by (Used in) Investing Activities $1,933,000 USD -658%
Common Stock, Shares Authorized 400,000,000 shares 0%
Common Stock, Shares, Issued 174,949,558 shares 12%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $42,421,000 USD -115%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $346,386,000 USD -19%
Interest Paid, Excluding Capitalized Interest, Operating Activities $2,140,000 USD -83%
Deferred Tax Assets, Valuation Allowance $225,248,000 USD 23%
Deferred Tax Assets, Gross $228,877,000 USD 18%
Operating Lease, Liability $7,278,000 USD -14%
Payments to Acquire Property, Plant, and Equipment $1,933,000 USD 658%
Lessee, Operating Lease, Liability, to be Paid $8,737,000 USD -18%
Property, Plant and Equipment, Gross $33,021,000 USD 3.2%
Operating Lease, Liability, Current $2,762,000 USD 61%
Lessee, Operating Lease, Liability, to be Paid, Year Two $3,086,000 USD 15%
Lessee, Operating Lease, Liability, to be Paid, Year One $2,722,000 USD 8.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.12 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $1,459,000 USD -35%
Lessee, Operating Lease, Liability, to be Paid, Year Three $2,179,000 USD -20%
Deferred Tax Assets, Operating Loss Carryforwards $134,571,000 USD 11%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5,000,000 shares 0%
Unrecognized Tax Benefits $0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four $750,000 USD -64%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization $981,000 USD 6.6%
Deferred Tax Assets, Net of Valuation Allowance $3,629,000 USD -67%
Share-based Payment Arrangement, Expense $39,022,000 USD 29%
Interest Expense $13,621,000 USD 92%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%